Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Colorcon
Baxter
Deloitte
AstraZeneca
Cipla
Cerilliant
Fuji

Generated: December 10, 2018

DrugPatentWatch Database Preview

Graviti Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for GRAVITI PHARMS, and what generic and branded alternatives to GRAVITI PHARMS drugs are available?

GRAVITI PHARMS has four approved drugs.



Summary for Graviti Pharms
US Patents:0
Tradenames:3
Ingredients:3
NDAs:4

Drugs and US Patents for Graviti Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Graviti Pharms FENOFIBRATE fenofibrate TABLET;ORAL 210606-002 Aug 17, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Graviti Pharms FENOFIBRATE fenofibrate TABLET;ORAL 210606-001 Aug 17, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Graviti Pharms ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 209912-002 Jun 18, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Graviti Pharms ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 209912-001 Jun 18, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Graviti Pharms ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 209912-003 Jun 18, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Graviti Pharms ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 209912-004 Jun 18, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Daiichi Sankyo
Cantor Fitzgerald
Express Scripts
AstraZeneca
Queensland Health
Healthtrust
Julphar
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.